Two rapidly expanding multidistrict litigations, the GLP-1 Receptor Agonists MDL (3094) and the Depo-Provera Brain Tumor MDL (3140), are reshaping pharmaceutical mass-tort practice across the United States. GLP-1 Drug Litigation: Ozempic, Wegovy, and Mounjaro Under...
The ongoing multidistrict litigation (MDL 2873) over Aqueous Film-Forming Foam (AFFF) has entered an unprecedented phase. Between August and September 2025, more than 37,000 new personal-injury cases were filed in the U.S. District Court for the District of South...
A group of Boy Scouts of America (BSA) abuse survivors has asked the U.S. Supreme Court to review the organization’s $2.46 billion bankruptcy settlement, arguing that the plan unlawfully prevents them from pursuing separate lawsuits against third parties such as local...
The Age of Invisible Harm The mass torts of the past targeted defective drugs, toxic spills, and dangerous products. The next generation targets institutions and platforms that allowed abuse, addiction, and exploitation to thrive. Today’s plaintiffs aren’t poisoned by...
The growing litigation over chemical hair relaxers has become one of the most closely watched mass torts in the United States. Sparked by studies linking long term use of these products to uterine and ovarian cancers, the lawsuits target several major cosmetic...
Roblox Corporation is once again facing legal scrutiny, this time over allegations that the popular gaming platform is intentionally designed to be addictive and harmful to children. A Missouri mother has filed a lawsuit in Nevada court on behalf of her child,...